Funds and ETFs Apeloa Pharmaceutical Co.,Ltd

Equities

000739

CNE000000Q45

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-05-15 EDT 5-day change 1st Jan Change
15.83 CNY +0.25% Intraday chart for Apeloa Pharmaceutical Co.,Ltd +1.47% +2.86%
Apeloa Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Active Pharmaceutical Ingredient (API) intermediates, contract development and manufacturing organization (CDMO), preparations and others, as well as import and export trade. The Company operates three businesses. The API intermediates business mainly includes cephalosporin series, penicillin series, psychiatric series, cardiovascular and cerebrovascular series and veterinary API intermediates series. The CDMO business mainly includes research and development services, commercial human drug projects, commercial veterinary drug projects and other commercial products. The preparation business mainly includes anti-infective, cardiovascular and cerebrovascular, psychiatric and anti-tumor preparation products. The Company mainly operates its businesses in domestic and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
15.83 CNY
Average target price
17.75 CNY
Spread / Average Target
+12.13%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000739 Stock
  4. Funds and ETFs Apeloa Pharmaceutical Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW